Citation: L. Mooney et al., Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients, INT J ANT A, 17(1), 2001, pp. 63-66
Authors:
Cairns, G
Kerr, KG
Beggs, CB
Sleigh, PA
Mooney, L
Keig, P
Donnelly, JK
Citation: G. Cairns et al., Susceptibility of Burkholderia cepacia and other pathogens of importance in cystic fibrosis to u.v. light, LETT APPL M, 32(3), 2001, pp. 135-138
Authors:
Denton, M
Hall, MJ
Todd, NJ
Kerr, KG
Littlewood, JM
Citation: M. Denton et al., Improved isolation of Stenotrophomonas maltophilia from the sputa of patients with cystic fibrosis using a selective medium, CL MICRO IN, 6(7), 2000, pp. 397-398
Authors:
Landers, P
Kerr, KG
Rowbotham, TJ
Tipper, JL
Keig, PM
Ingham, E
Denton, M
Citation: P. Landers et al., Survival and growth of Burkholderia cepacia within the free-living amoeba Acanthamoeba polyphaga, EUR J CL M, 19(2), 2000, pp. 121-123
Authors:
M'Zali, FH
Chanawong, A
Kerr, KG
Birkenhead, D
Hawkey, PM
Citation: Fh. M'Zali et al., Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL, J ANTIMICRO, 45(6), 2000, pp. 881-885
Authors:
Beggs, CB
Kerr, KG
Donnelly, JK
Sleigh, PA
Mara, DD
Cairns, G
Citation: Cb. Beggs et al., An engineering approach to the control of Mycobacterium tuberculosis and other airborne pathogens: a UK hospital based pilot study, T RS TROP M, 94(2), 2000, pp. 141-146
Citation: F. Maudsley et Kg. Kerr, Microbiological safety of essential oils used in complementary therapies and the activity of these compounds against bacterial and fungal pathogens, SUPP CARE C, 7(2), 1999, pp. 100-102
Citation: Kg. Kerr et al., Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy, SUPP CARE C, 7(1), 1999, pp. 28-30